Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 11985356

Antiaging technology and pseudoscience.

Aubrey D N J de Grey·Leonid Gavrilov·S Jay Olshansky·L Stephen Coles·Richard G Cutler·Michael Fossel·S Mitchell Harman
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

AdvertisingAgingHumansLongevityPeriodicals as TopicPublishingResearchTerminology as TopicLetterComment

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Aubrey D N J de Grey, Leonid Gavrilov, S Jay Olshansky, L Stephen Coles, Richard G Cutler, Michael Fossel, S Mitchell Harman. 2002-04-26. Antiaging technology and pseudoscience.. https://doi.org/10.1126/science.296.5568.656a

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

New Zealand general practitioners' views on direct-to-consumer advertising of prescription medicines: a qualitative analysis.

AIM: To explore the range of opinions held by a sample of New Zealand general practitioners (GPs) toward direct-to-consumer advertising (DTCA) of prescription medicines. METHOD: Depth interviews were conducted with 20 GPs. The interview protocol examined several aspects of the debate over DTCA, including its appropriateness, informativeness, and effect on doctors' relationships with their patients. The interview included five sets of forced choice statements that summarised key strands of the debate; these were used as preliminary stimuli to elicit doctors' views. RESULTS: The results reveal a low incidence of DTCA-related queries and a wide range of views on the appropriateness of DTCA. Respondents favourably viewed DTCA's ability to increase awareness of some health conditions, although they had serious concerns about the adequacy of the risk and contraindication information provided as well as the general absence of specific cost details. While some doctors resented having to deal with questions arising from DTCA, few considered that this advertising undermined the relationship they have with their patients. CONCLUSIONS: Overall, while the majority of respondents did not support a ban on DTCA, most of them thought that stricter regulation was necessary. These findings clarify the conclusions drawn from quantitative studies, and suggest doctors' views of DTCA may be more complex than previously reported.

Advertising↗
PubMed2005

Advertising of medicines on New Zealand television.

AIMS: To measure the frequency of advertising of medicines on New Zealand television and to describe the distribution of advertising. METHODS: A stratified random sample of 35 days (577.5 hours) of television was video-recorded, including five free to air channels for each day of the week. Videotapes were watched, then advertisements were recorded on a pre-designed form. RESULTS: 340 advertisements for medicines were identified, an average of 1 per 102 minutes; 37% of advertisements were for medicines available for general sale, 24% for dietary supplements, 21% for pharmacy- or pharmacist-only medicines, and 18% for prescription-only medicines. Four channels had similar amounts of advertising. Channels varied in the kind of medicines they had advertisements for. There were more advertisements per hour in the afternoon than in the morning or evening. Advertisements for medicines were found in a wide range of programmes, including children's programmes. CONCLUSIONS: People who watch particular programmes, or who watch television at some times of days may be exposed to considerably more than one medicine's advertisement per 102 minutes. While this study does not examine the effect of medicines advertisements on consumer behaviour, previous research suggests this may be significant.

Advertising↗